Skip to main content
. 2017 Nov 30;12(11):e0189057. doi: 10.1371/journal.pone.0189057

Table 1. Patients’ characteristics and prognostic factors of the survivors and non-survivors, and according to AKIN stage.

Total
(n = 216)
Survivors
(n = 40)
Non-survivors
(n = 176)
p-value AKIN0
(n = 26)
AKIN1
(n = 15)
AKIN2
(n = 26)
AKIN3
(n = 149)
p-value
Age (years) 52.8±15.0 54.3±14.2 52.5±15.2 0.550 53.0±17.3 59.3±14.8 55.8±17.8 51.6±14.0 0.221
Sex (male:female) 186:30 36:4 150:26 0.593 24:2 11:4 20:6 131:18 0.163
TBSA burned (%) 55.8±25.2 35.3±23.4 60.4±23.3 <0.001 66.3±24.3 60.5±25.9 45.3±25.4 55.3±24.7 0.016
Inhalation Injury 103(47.7%) 16(40.0%) 87(49.4%) 0.367 13(50.0%) 8(53.3%) 9(34.6%) 73(49.0%) 0.546
Weight 68.2±11.3 68.7±8.9 68.1±11.7 0.438 67.2±13.8 67.5±9.5 65.0±10.7 69.0±11.0 0.320
ABSI score 10.6±2.5 8.5±2.5 11.1±2.3 <0.001 11.8±2.2 11.3±2.7 9.7±2.5 10.5±2.5 0.009
APACHE of admission 52.4±18.9 47.2±18.6 53.6±18.8 0.117 53.6±13.2 45.9±18.9 58.6±15.2 51.8±20.1 0.074
SAPS of admission 42.7±9.9 38.6±9.8 43.6±9.7 0.003 42.6±8.4 40.7±12.3 45.1±10.1 42.5±9.9 0.975
LOSICU (days) 28.9±28.5 58.9±32.7 22.1±22.6 <0.001 30.2±37.5 22.7±12.0 24.4±20.8 30.1±29.2 0.896
LOS (days) 34.3±37.5 87.6±43.4 22.2±22.6 <0.001 36.7±44.8 22.7±12.0 25.9±21.8 36.5±39.8 0.898
CRRT
    Initiation day 12.4±13.3 16.2±12.2 11.6±13.4 0.011 10.6±6.5 13.0±9.4 15.1±16.0 12.2±14.0 0.767
    Intensity(mL/kg/h) 30.1±4.7 29.6±4.0 30.2±4.8 0.438 31.0±6.5 30.2±4.1 31.5±5.0 29.6±4.3 0.320
    Duration (days) 11.7±13.6 20.8±16.7 9.6±11.9 <0.001 8.0±9.0 9.9±10.2 8.5±9.7 13.1±14.9 0.148
    Sepsis 121(56.0%) 22(55.0%) 99(56.2%) 1.000 13(50.0%) 9(60.0%) 11(42.3%) 88(59.1%) 0.388
    APACHE III at start 70.7±18.6 60.0±15.6 73.2±18.4 <0.001 56.5±16.0 69.9±18.8 66.6±19.3 74.0±17.7 <0.001
    SAPS II at start 49.4±10.8 42.7±9.1 50.9±10.6 <0.001 45.8±9.8 49.0±8.5 48.2±13.2 50.2±10.7 0.055
    SOFA at start 8.8±2.9 7.0±2.4 9.2±2.9 <0.001 7.1±3.1 7.9±3.0 8.5±3.0 9.2±2.7 0.003
    MAP 59.5±17.0 74.4±19.9 56.0±14.2 <0.001 64.8±18.2 56.9±15.5 60.7±14.5 58.6±17.3 0.403
Supportive cares
    Ventilator 197(91.2%) 26(65.0%) 171(97.2%) <0.001 24(92.3%) 15(100%) 25(96.2%) 133(89.3%) 0.395
    Vasopressors 133(61.6%) 14(35.0%) 119(67.6%) <0.001 14(53.8%) 10(66.7%) 17(65.4%) 92(61.7%) 0.806
Prognostic Factors
    pH 7.23±0.09 7.26±0.09 7.20±0.08 <0.001 7.24±0.08 7.22±0.07 7.23±0.11 7.20±0.08 0.038
    Potassium (mEq/L) 4.7±0.8 4.5±0.7 4.8±0.8 0.104 4.6±0.7 4.6±0.6 4.6±0.9 4.8±0.8 0.386
    BUN (mg/dL) 42.7±17.7 41.6±15.2 42.9±18.2 0.890 42.4±18.0 38.6±22.6 38.1±16.5 43.9±17.2 0.264
    Creatinine (mg/dL) 2.2±1.4 2.9±2.1 2.0±1.1 0.002 1.1±0.4 1.2±0.5 1.6±0.7 2.6±1.5 <0.001
    Urine/kg/h (cc) 0.7±0.6 0.8±0.7 0.7±0.5 0.300 1.5±0.7 1.1±0.4 0.7±0.4 0.5±0.4 <0.001
    Lactate (mmol/L) 2.5±1.8 1.7±1.2 2.7±1.9 <0.001 2.1±1.3 2.7±1.7 3.1±2.7 2.5±1.7 0.378
    WBC (x103/μL) 17.1±10.2 16.5±11.9 17.2±9.8 0.377 14.8±9.1 18.5±9.9 15.6±9.6 17.6±10.5 0.296
    Platelet (x103/μL) 109.0±96.6 168.2±127.8 95.5±82.7 <0.001 131.5±136.6 136.9±117.1 103.9±76.3 103.1±89.0 0.582
    PF ratio 159.4±87.2 197.8±63.1 150.7±89.6 <0.001 146.4±75.5 146.0±98.3 161.9±97.9 162.6±86.5 0.725
    TB (mg/dL) 1.5±1.4 1.1±0.9 1.6±1.5 0.026 1.1±1.4 1.8±1.4 1.9±1.9 1.5±1.3 0.014
Mortality 176(81.5%) 20(76.9%) 15(100%) 23(88.5%) 118(79.5%)2 0.163

n, number; FB, Flame Burn; SB, Scald Burn; EB, Electrical Burn; ChB, Chemical Burn; CoB, Contact Burn; %TBSA burned, percentage of total body surface area burned; LOSICU, length of stay in ICU stay; LOS, length of hospital stay